AI Engines For more Details: Perplexity Kagi Labs You
Contraception: Norethindrone is commonly used in combination with estrogen in oral contraceptive pills (birth control pills) to prevent pregnancy. It works by inhibiting ovulation (the release of an egg from the ovary), thickening cervical mucus to impede sperm penetration, and altering the uterine lining to prevent implantation of a fertilized egg. Norethindrone-only pills (progestin-only pills or minipills) are also available and primarily work by thickening cervical mucus and altering the uterine lining.
Menstrual Disorders: Norethindrone-containing contraceptive pills may be prescribed to regulate menstrual cycles and treat menstrual disorders such as irregular or heavy menstrual bleeding (menorrhagia). By stabilizing hormonal fluctuations, norethindrone can help promote regular and lighter menstrual periods. Progestin-only pills may also be used to manage menstrual irregularities.
Hormone Replacement Therapy (HRT): Norethindrone, often in combination with estrogen, is used in hormone replacement therapy for postmenopausal women to alleviate symptoms of menopause, such as hot flashes, vaginal dryness, and mood changes. It can help replace the hormones that the body stops producing after menopause, thereby reducing symptoms and preventing bone loss.
Endometriosis: Norethindrone may be prescribed to treat endometriosis, a condition in which tissue similar to the lining of the uterus grows outside the uterus, causing pain and other symptoms. By suppressing ovulation and thinning the uterine lining, norethindrone can help alleviate symptoms associated with endometriosis, such as pelvic pain and heavy menstrual bleeding.
Polycystic Ovary Syndrome (PCOS): Norethindrone may be used to regulate menstrual cycles and reduce androgen levels in women with polycystic ovary syndrome (PCOS), a hormonal disorder characterized by irregular periods, excess hair growth, and ovarian cysts. By inhibiting ovulation and lowering androgen levels, norethindrone can help improve symptoms of PCOS.
Breast Cancer: In some cases, norethindrone may be used as part of the treatment for advanced breast cancer, particularly in postmenopausal women. It may help slow the growth of hormone receptor-positive breast cancer cells by blocking estrogen production in the body.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Simiaoa | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Dysosmobacter welbionis | species | Decreases |
0 | 1 | Alistipes indistinctus | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.4 | |
Acne | 0 | 0 | |
ADHD | 0.6 | 0.1 | 5 |
Age-Related Macular Degeneration and Glaucoma | 0.1 | 0.2 | -1 |
Allergic Rhinitis (Hay Fever) | 0.5 | 0.6 | -0.2 |
Allergies | 1.6 | 0.9 | 0.78 |
Allergy to milk products | 0.8 | 0.6 | 0.33 |
Alopecia (Hair Loss) | 0.4 | 0.1 | 3 |
Alzheimer's disease | 1.8 | 2.1 | -0.17 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.1 | 0.7 | 0.57 |
Ankylosing spondylitis | 1.9 | 0.8 | 1.37 |
Anorexia Nervosa | 0.4 | 0.8 | -1 |
Antiphospholipid syndrome (APS) | 0.6 | 0.4 | 0.5 |
Asthma | 1.3 | 0.4 | 2.25 |
Atherosclerosis | 0.9 | 0.2 | 3.5 |
Atrial fibrillation | 1.2 | 1.1 | 0.09 |
Autism | 1.2 | 3.6 | -2 |
Autoimmune Disease | 0.4 | 0 | 0 |
Barrett esophagus cancer | 0.2 | 0.2 | |
benign prostatic hyperplasia | 0.4 | 0.1 | 3 |
Biofilm | 0.7 | 0.7 | |
Bipolar Disorder | 1.4 | 0.4 | 2.5 |
Brain Trauma | 0 | 0.4 | 0 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 0.2 | 0.2 | 0 |
Carcinoma | 1.3 | 0.5 | 1.6 |
Celiac Disease | 0.9 | 1.5 | -0.67 |
Cerebral Palsy | 0.2 | 0.3 | -0.5 |
Chronic Fatigue Syndrome | 1.7 | 2.2 | -0.29 |
Chronic Kidney Disease | 0.9 | 1.2 | -0.33 |
Chronic Lyme | 0.1 | -0.1 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.7 | 0.6 | 0.17 |
Chronic Urticaria (Hives) | 0.8 | 0.1 | 7 |
Coagulation / Micro clot triggering bacteria | 1 | 0.2 | 4 |
Cognitive Function | 0.5 | 0 | 0 |
Colorectal Cancer | 1.7 | 0.7 | 1.43 |
Constipation | 1.1 | 1.1 | |
Coronary artery disease | 1.1 | 0.3 | 2.67 |
COVID-19 | 1.9 | 2.2 | -0.16 |
Crohn's Disease | 2.8 | 1.7 | 0.65 |
Cushing's Syndrome (hypercortisolism) | 0.1 | -0.1 | |
cystic fibrosis | 0.7 | 0.1 | 6 |
d-lactic acidosis (one form of brain fog) | 0.5 | 0.5 | |
deep vein thrombosis | 0.9 | 0.3 | 2 |
Denture Wearers Oral Shifts | 0.4 | 0.4 | |
Depression | 3.1 | 2.6 | 0.19 |
Dermatomyositis | 0 | 0 | |
Eczema | 0.7 | 0 | 0 |
Endometriosis | 1.2 | 1.2 | 0 |
Eosinophilic Esophagitis | 0.1 | 0.2 | -1 |
Epilepsy | 1.1 | 0.6 | 0.83 |
erectile dysfunction | 0.5 | 0 | 0 |
Fibromyalgia | 0.5 | 0.3 | 0.67 |
Functional constipation / chronic idiopathic constipation | 2 | 0.5 | 3 |
gallstone disease (gsd) | 1.2 | 0.1 | 11 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.4 | 0.5 | -0.25 |
Generalized anxiety disorder | 1 | 0.1 | 9 |
Gout | 0.5 | 0.1 | 4 |
Graves' disease | 0.6 | 0.6 | 0 |
Gulf War Syndrome | 0 | 0 | |
Halitosis | 0.4 | 0.4 | |
Hashimoto's thyroiditis | 0.5 | 1 | -1 |
Heart Failure | 2 | 0.3 | 5.67 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 1 | 0.2 | 4 |
High Histamine/low DAO | 0.5 | 0.2 | 1.5 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.5 | |
hyperglycemia | 1.1 | 0.4 | 1.75 |
Hyperlipidemia (High Blood Fats) | 0.4 | 0.4 | |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 1.6 | 1.6 | 0 |
Hypothyroidism | 0 | 0 | |
Hypoxia | 0.3 | 0.3 | |
IgA nephropathy (IgAN) | 0.5 | 1.3 | -1.6 |
Inflammatory Bowel Disease | 2.2 | 3.3 | -0.5 |
Insomnia | 0.2 | 0.9 | -3.5 |
Intelligence | 0.7 | 0.1 | 6 |
Intracranial aneurysms | 0.5 | 0.5 | |
Irritable Bowel Syndrome | 1.7 | 1.3 | 0.31 |
ischemic stroke | 1.1 | 0.6 | 0.83 |
Liver Cirrhosis | 2.2 | 1.4 | 0.57 |
Long COVID | 1.5 | 2.7 | -0.8 |
Low bone mineral density | 0.5 | -0.5 | |
Lung Cancer | 0.8 | 0.3 | 1.67 |
Lymphoma | 0.4 | 0.4 | |
Mast Cell Issues / mastitis | 0.5 | 0.2 | 1.5 |
ME/CFS with IBS | 0.1 | 0.5 | -4 |
ME/CFS without IBS | 0.7 | -0.7 | |
Menopause | 0.3 | 0.3 | |
Metabolic Syndrome | 2.5 | 1.4 | 0.79 |
Mood Disorders | 3 | 2 | 0.5 |
multiple chemical sensitivity [MCS] | 0.2 | 0.1 | 1 |
Multiple Sclerosis | 1.3 | 1.6 | -0.23 |
Multiple system atrophy (MSA) | 0.1 | 0.2 | -1 |
myasthenia gravis | 0.4 | 0.4 | |
neuropathic pain | 0.9 | -0.9 | |
Neuropathy (all types) | 0.5 | -0.5 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.8 | 1 | 0.8 |
NonCeliac Gluten Sensitivity | 0.1 | 0.1 | 0 |
Obesity | 2.6 | 1.6 | 0.63 |
obsessive-compulsive disorder | 2.3 | 0.1 | 22 |
Osteoarthritis | 0.3 | 0.5 | -0.67 |
Osteoporosis | 0.8 | 0.1 | 7 |
pancreatic cancer | 0.1 | 0.1 | |
Parkinson's Disease | 2.1 | 2.2 | -0.05 |
Polycystic ovary syndrome | 2.2 | 1.2 | 0.83 |
Postural orthostatic tachycardia syndrome | 0 | 0 | |
Premenstrual dysphoric disorder | 0 | 0.2 | 0 |
primary biliary cholangitis | 0.2 | 0.1 | 1 |
Primary sclerosing cholangitis | 0.9 | 1.1 | -0.22 |
Psoriasis | 0.8 | 0.7 | 0.14 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.3 | 0.4 | 4.75 |
Rosacea | 0.2 | 0.1 | 1 |
Schizophrenia | 1.8 | 1.1 | 0.64 |
scoliosis | 0.6 | 1.2 | -1 |
sensorineural hearing loss | 0.1 | 0.1 | |
Sjögren syndrome | 1.1 | 0.4 | 1.75 |
Sleep Apnea | 0.4 | 0.1 | 3 |
Slow gastric motility / Gastroparesis | 0.9 | 0 | 0 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.7 | 0 | 0 |
Stress / posttraumatic stress disorder | 0.9 | 0.4 | 1.25 |
Systemic Lupus Erythematosus | 1.3 | 1.2 | 0.08 |
Tic Disorder | 0.2 | 0.1 | 1 |
Tourette syndrome | 0.1 | -0.1 | |
Type 1 Diabetes | 1.3 | 0.9 | 0.44 |
Type 2 Diabetes | 2.2 | 1.4 | 0.57 |
Ulcerative colitis | 2 | 1.4 | 0.43 |
Unhealthy Ageing | 0.9 | 0.2 | 3.5 |
Vitiligo | 0.9 | 0.3 | 2 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]